CTIS2023-510280-35-00
招募中
1 期
Effective strategy of withdrawal of pharmacological treatment of urinary incontinence in children (StayDry) - StayDry-2023
Region Midtjylland0 个研究点目标入组 216 人2024年1月9日
适应症Daytime urinary incontinenceMedDRA version: 20.0Level: LLTClassification code: 10008523Term: Childhood incontinence Class: 10038359MedDRA version: 21.1Level: LLTClassification code: 10021642Term: Incontinence of urine Class: 10038359Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Daytime urinary incontinence
- 发起方
- Region Midtjylland
- 入组人数
- 216
- 状态
- 招募中
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •The participants custody holder(s) must voluntarily sign and date an informed consent prior to initiation any study specific procedures., Age 5 to 14 years (inclusive) at the time of signing the consent., Diagnose with urinary incontinence as per ICCS criteria., Pharmacological treatment with solifenacin and/or mirabegron., Continence has been achieved on pharmacological therapy with solifenacin and/or mirabegron., Previously withdrawal attempts are accepted., Continence remained on the same dosage of medication for a minimum of three months.
排除标准
- •Neurogenic detrusor overactivity (neurogenic bladder)
结局指标
主要结局
未指定
相似试验
招募中
4 期
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)Urinary Incontinence in ChildrenNCT06465576University of Aarhus216
招募中
不适用
Optimal strategy for stopping medication for chronic functional constipation in children: Randomized controlled multicenter studyKCT0006286Hallym University Medical Center120
招募中
1 期
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE)Heart FailureMedDRA version: 20.0Level: LLTClassification code: 10019279Term: Heart failure Class: 10007541Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2023-504946-70-00Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia60
进行中（未招募）
1 期
Withdrawal of pharmacological treatment in patients responding to cardiac resynchronization therapy: Open and randomized studyHeart failureTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2021-001327-41-ESFundación para la formación e investigación sanitarias de la Región de Murcia60
尚未招募
不适用
Prevention of medication errors in emergency settings.Health Condition 1: Z048- Encounter for examination and observation for other specified reasonsCTRI/2024/02/062206I